510(k) K852767

ERYTHOCYTE CREATINE by Panmed, Inc. — Product Code JLA

K852767 is an FDA 510(k) premarket notification submitted by Panmed, Inc. for the device "ERYTHOCYTE CREATINE". The FDA issued a decision of Substantially Equivalent on Nov 13, 1986. The device falls under product code JLA (Conversion To Creatinine, Creatine), a Class I device regulated under 21 CFR 862.1210. Panmed, Inc. has 15 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Nov 13, 1986
Date Received
Jun 28, 1985
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Conversion To Creatinine, Creatine
Device Class
Class I
Regulation Number
862.1210
Review Panel
CH
Submission Type
510(k) Exempt

Need the full FDA record for Panmed, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K852767. Report a data issue: hello@regdatalab.com.